Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Insulin glargine 💬
(Insulin glargine (USAN/INN), Insulin glargine (genetical recombination) (JP18), Insulin glargine (genetical recombination) [Insulin glargin biosimilar 1] (JAN), Insulin glargine (genetical recombination) [Insulin glargin biosimilar 2] (JAN), INSULIN GLARGINE SOLOSTAR)
[1] Insulin glargine (Insulin glargine recombinant)[1] Insulin glargine[1] INSR 💬 [22] AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬[1] 299 💬